Cargando…
Basket Trials for Intractable Cancer
Currently, genomic characterization has become standard of care for tumor types such as non-small cell lung cancer, breast cancer, melanoma, and colorectal cancer. A deep understanding of genomic alterations in different tumor types would help identify potentially actionable genomic changes which oc...
Autores principales: | Qin, Bao-Dong, Jiao, Xiao-Dong, Liu, Ke, Wu, Ying, He, Xi, Liu, Jun, Qin, Wen-Xing, Wang, Zhan, Zang, Yuan-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473081/ https://www.ncbi.nlm.nih.gov/pubmed/31032221 http://dx.doi.org/10.3389/fonc.2019.00229 |
Ejemplares similares
-
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)
por: Jiao, Xiao-Dong, et al.
Publicado: (2023) -
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
por: Duan, Xiao-Peng, et al.
Publicado: (2023) -
The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review
por: Qin, Bao-Dong, et al.
Publicado: (2018) -
MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer
por: Liu, Ke, et al.
Publicado: (2019) -
Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report
por: He, Xi, et al.
Publicado: (2021)